Abstract: A system of performing a medical procedure, such as surgery, is provided. The system comprises a compression member for compressing a body portion and a means for controlling the compression. Methods and devices for performing the medical procedure are also provided.

Abstract: An apparatus for outputting heart sounds includes an implantable system and an external system. The implantable system includes a sensor for generating sensed signals representing detected heart sounds, an interface circuit and a control circuit for receiving the sensed signals, generating data representing the heart sounds therefrom, and transmitting the data to the external system via the interface circuit. The external system includes an interface circuit for communicating with the implantable system, and a control circuit for receiving the data representing the heart sounds and for generating control signals that cause an output device to generate outputs representing the sounds. The implantable system may also include a sensor(s) for detecting cardiac electrical signals. In this case, outputs representing the cardiac electrical signals are also output.

Abstract: An implantable cardioverter/defibrillator includes an active can electrode and a high-voltage lead that can be electrically isolated from one another by opening a switch between them. The performance of the high-voltage lead and the can electrode can then be independently monitored, thus indicating which lead is inoperable, should one become inoperable. If a lead becomes inoperable, the implantable device can then reconfigure an electrical pathway such as a cardioversion and/or a defibrillation pathway by excluding the inoperable lead. By separating the high-voltage lead from the can electrode, pseudo ECG measurements can also be taken and utilized by the implantable device.

Abstract: A cardiac pacemaker is configured to estimate the intrinsic atrial conduction time from sensed signals detected by an atrial sensing channel. Atrial conduction delays have been found to be associated with the onset of atrial tachyarrhythmias. Upon detection of an atrial conduction time above a specified limit value, the pacemaker is programmed to switch from a normal pacing mode to an atrial pacing preference mode.

Abstract: One embodiment of the present invention provides an implantable cardioverter-defibrillator for subcutaneous positioning between the third rib and the twelfth rib within a patient, the implantable cardioverter-defibrillator including a housing including a first electrode; a telescoping lead assembly including a second electrode, wherein the telescoping lead assembly is electrically and mechanically coupled to the housing; and an electrical circuit located within and electrically coupled to the housing.

Abstract: An apparatus and method for adjusting the performance of an implanted device based on data including contextual information. Contextual information, including operational and performance data concerning the implanted device as well as the patient with the implanted device, is stored by a portable electronic device. In one embodiment, the portable electronic device is adapted for battery operation and includes a personal digital assistant (PDA). The portable electronic device is adapted for use as an interface to conduct wireless communications with the implanted device. In one embodiment, the portable electronic device interfaces with a clinical programmer for use by a physician.

Abstract: A method is provided for controlling an automatic external defibrillator without stopping CPR (primarily chest compressions). While chest compressions continue to be applied to the victim, the system differentiates between (1) a perfusing rhythm that has the capability of leading to a beating heart without a shock and (2) ventricular fibrillation (VF) which sometimes occurs in the presence of ventricular tachycardia (VT), in which there is no capability for leading to a beating heart without a shock. Defibrillation shocks should be applied only when needed and that is in the presence of VF and sometimes in the presence of VT. Electrocardiographic (ECG or EKG) signals obtained from electrodes applied to the patient's chest are analyzed so that the presence of a QRS signal characteristic of a rhythm which has the potential of supporting a beating heart, or the absence of a QRS signal which indicates ventricular fibrillation, may be detected in the presence of artifacts resulting from chest compressions.

Abstract: An implantable cardioverter-defibrillator for subcutaneous positioning between the third rib and the twelfth rib within a patient, the implantable cardioverter-defibrillator including a housing, wherein at least a portion of the housing is curved; an electrical circuit; and at least one electrically conductive surface integrally positioned on at least one portion of the house, wherein at least one electrically conductive surface is coupled to the electrical circuit.

Abstract: An implantable pump system including an external driver. The implantable pump is driven by the external driver during normal operation but may also operate on a-battery. The external driver is used to drive the pump with the mechanical energy of the impeller also being used to charge the battery. The external driver is also useful during emergency situations to directly drive the pump if the battery or internal coils should fail. The pump is also preferably implanted in a subpectoral location outside the patient's rib cage.

Abstract: An apparatus for using automatically retractable cables with a defibrillator. The Apparatus provides (a) a defibrillator comprising a power source electrically connected between a first wire and a second wire; and (b) an automatic rotatable housing automatically retracting the first wire and the second wire wound around the rotatable housing. A circular spring can also be used to exert rotational force on the rotatable housing and connect the cables to the power source.

Abstract: One embodiment of the present invention provides an implantable cardioverter defibrillator for subcutaneous positioning between the third rib and the twelfth rib within a patient, the implantable cardioverter-defibrillator including a housing; an electrical circuit located within the housing; a first electrode coupled to the electrical circuit and located on the housing; and a second electrode coupled to the electrical circuit.

Abstract: Detection of arrhythmias is facilitated using irregularity of ventricular beats measured by delta-RR (?RR) intervals that exhibit discriminatory signatures when plotted in a Lorenz scatter-plot. An “AF signature metric” is established characteristic of episodes of AF that exhibit highly scattered (sparse) distributions or formations of 2-D data points. An “AFL signature metric” is established characteristic of episodes of AFL that exhibit a highly concentrated (clustered) distribution or formation of 2-D data points. A set of heart beat interval data is quantified to generate highly scattered (sparse) formations as a first discrimination metric and highly concentrated (clustered) distributions or formations as a second discrimination metric. The first discrimination metric is compared to the AF signature metric, and/or the second discrimination metric is compared to the AFL signature metric. AF or HFL is declared if the first discrimination metric satisfies either one of the AF signature metric.

Abstract: A capture detection algorithm in which atrial capture is detected and distinguished. Further, an immediate measurement of the capture threshold is implemented when a pacemaker switches a lead's polarity from bipolar to unipolar in response to a detected lead failure, in either one or both chambers. Atrial chamber reset (ACR) and AV conduction (AVC), implemented to measure an atrial pacing threshold, are comparatively measured to enable measurement of the atrial pacing threshold. The data that is used to choose between ACR and AVC methods is used to determine the progression of the patient's disease state. Some of the significant aspects of the invention include enablement of accurate threshold measurements, including calculation of stability criteria, precise interval measurements and the use of reference interval to determine capture and loss of capture.

Abstract: The present invention provides for an encryption apparatus, system, and method in which data from an Implantable Medical Device (IMD) and a data center could be transferred based on a differentiated encryption system. The encryption scheme allows for the differentiation, segregation, and classification of data at required or needed levels of security. Before transfer of the data, either from an IMD or any other part of a support network for the IMDs, the encryption device begins to distinguish the data. The variable data is then classified based on various levels of security having distinct encryption protocols. After classification the data is encrypted based on the data's level of security. The data is then transmitted. Upon being received the data is then segregated based on whether the data is encrypted. The encrypted data is then de-encrypted and interpreted.

Abstract: A defibrillator electrode pad assembly has an adhesive release sheet configured to be removed while the electrode pad is held in a desired position on the patient. The release sheet is folded in a substantially U-shaped configuration and includes a pull-tab to be grasped by the user. The electrode pad is applied to the patient by positioning the electrode pad on the patient's skin with the release sheet facing the skin and in contact with or closely adjacent to the skin, without lifting the electrode pad from the patient's skin, pulling on the pull-tab to remove the release sheet to expose the adhesive portion, and adhering the adhesive portion to the patient's skin.

Abstract: A method and apparatus for cardioverting the atrium of a human heart that includes insertion of first and second elongated electrodes tranvenously into the heart and associated vessels. One electrode is preferably located in the coronary sinus and great vein of the heart. The other electrode is preferably located in the vicinity of the right atrium of the heart, spaced from the electrode located in the coronary sinus. In response to detection of fibrillation or in response to manual triggering, a defibrillation pulse is applied between the first and second electrodes to effect atrial cardioversion. Further, after delivery of a successful defibrillation shock, the width of intrinsic p-waves are monitored and bi-atrial pacing is temporarily initiated if the width exceeds a preset or programmable threshold.

Abstract: An body implantable stimulation lead is provided including tip electrode patterns and configurations producing low noise, clean sensed signals devoid of far field components, such sensed signals being generated irrespective of the direction of the incident depolarization wavefront. The invention also provides high pacing impedances and advantageous anode-to-cathode surface area ratios. Further, implantable leads utilizing the features of the present invention are particularly suitable for left side stimulation therapies.

Abstract: A process for the presentation of data stored in an active implantable medical device to assist a practitioner in making a diagnosis.

Abstract: An apparatus and method for processing heart rate information by wirelessly transferring the information between a heart rate monitor and a personal computer device (PCD). The information includes programming information and heart rate or training information collected during use of the heart rate monitor. The PCD may include a personal digital assistant (PDA), a pocket personal computer (pocket PC), or a laptop computer. The information is transferred over an infrared, sonic, audible, ultrasonic, magnetic, radio frequency, IEEE 802.11, or Bluetooth-based communication link.

Abstract: A system and method of detecting and displaying parameter interactions. A medical device system has a medical device and a programming interface, wherein the medical device includes a plurality of features which can be programmed via the programming interface. A plurality of icons is defined, wherein the plurality of icons includes a first icon, a second icon and a third icon, wherein the first icon indicates correctness, wherein the second icon warns of a parameter interaction and wherein the third icon warns of impermissible parameter settings. Parameter interactions between feature parameters are identified and each of the parameter interactions is associated with one of the plurality of icons. A parameter value is accepted and examined to determine if it causes a parameter interaction. If the parameter value causes a parameter interaction, the icon associated with the parameter interaction is displayed.